I appear to be hitting a rate limit on the search tool. Let me work with the results I've already gathered, which are substantial and cover the key recent developments. Now I have enough material to write a rigorous synthesis. Let me compose it.
---
The single most promising near-term path to field-deployable blight-resistant American chestnuts is The American Chestnut Foundation's recurrent genomic selection (RGS) breeding program. Within this program, TACF is pursuing four parallel breeding tracks using backcross hybrid trees: one to maximize blight resistance, one to balance gains in blight and Phytophthora root rot (PRR) resistance simultaneously, one to maximize PRR resistance — all while maintaining a minimum of 70% American chestnut ancestry — and a fourth non-hybrid track to maximize blight resistance among offspring of large surviving American chestnuts. This multi-track approach is now the organization's central strategy, especially after TACF announced in a December 8 press release that it was withdrawing support for the Darling 58 genetically engineered American chestnut tree "for several pending regulatory petitions that would authorize distribution of transgenic Darling trees outside permitted research plots." The RGS pipeline uses DNA markers to predict blight resistance from genotype rather than waiting years for phenotypic inoculation data, which radically compresses generational breeding cycles and makes large-scale production of restoration-grade seed stock a realistic near-term prospect.
The most significant recent scientific development is the publication of a landmark paper in *Science* validating the genomic selection methodology. In February 2026, the American Chestnut Foundation announced that a new paper was published in *Science* by lead author and TACF's Director of Science Dr. Jared Westbrook, which "demonstrates that recurrent genomic selection (RGS), a method long used in agriculture and animal breeding, can predict blight resistance in chestnut trees using DNA data alone," resulting in "substantially shorter breeding cycles." This matters enormously because the traditional backcross breeding approach, initiated in the 1980s, has been hampered by the long generation times of forest trees and the discovery that blight resistance is polygenic rather than simply inherited. A validated genomic prediction model means that TACF can now select parent trees for the next breeding cycle based on genotype within months of germination, rather than waiting five or more years for inoculation results. Meanwhile, the transgenic program at SUNY-ESF continues parallel work: their DarWin chestnuts ramp up expression of OxO specifically in response to wounding and blight infection, with transformations including OxO driven by a citrus phloem promoter to target the first tissues disrupted by the fungus, a germin-like protein gene from chestnut, and a laccase gene from Chinese chestnut that may help strengthen cell walls. These next-generation constructs could eventually offer stacked resistance, but they face a long regulatory road.
The biggest remaining bottlenecks are both institutional and biological. On the regulatory side, petitions for deregulation of the Darling lines were submitted to FDA as part of the tri-agency review process (USDA APHIS, EPA, FDA), but no final FDA decision has been publicly announced as of 2025. The USDA confirms that the petition for deregulation is still pending and that they are waiting for additional information from ESF as to how they want to proceed. This regulatory uncertainty — the first case of a transgenic forest tree being considered for open environmental release for conservation purposes — has no established timeline and creates planning paralysis for restoration practitioners. On the scientific side, the challenge is that blight resistance alone is insufficient for successful reintroduction. Breeding for a blight-resistant tree began over 100 years ago, and a backcross breeding approach incorporating blight-resistant genes from Chinese chestnut was initiated in the 1980s, but restoration of the American chestnut will require more than a blight-resistant tree — trees must also tolerate PRR, compete in contemporary forest canopies that have been occupied by oaks and other species for a century, and carry sufficient genetic diversity to sustain viable wild populations across the species' former range.
New funding would have the highest impact-per-dollar if directed at scaling TACF's RGS breeding infrastructure — specifically, expanding genotyping throughput, establishing regionalized breeding orchards to capture local adaptation across the species' historic range, and supporting the controlled-pollination labor force needed to execute hundreds of planned crosses per cycle. TACF's RGS program already has a clear framework of four parallel breeding tracks, but realizing them requires propagating and genotyping thousands of seedlings annually across multiple geographic regions. A secondary high-impact investment would be in field reintroduction science: more than 60 American chestnut seedlings were planted by Forest Service employees and volunteers at Land Between the Lakes National Recreation Area in Kentucky in May 2024, with multiple layers of protection to give them the best chance for survival. Such pilot plantings generate the critical silvicultural data — on competition, site preparation, browsing pressure, and disease exposure — needed to translate breeding gains into actual forest restoration. Without parallel investment in reintroduction ecology, even a perfectly blight-resistant tree will fail to re-establish in the radically altered forests of the twenty-first-century eastern United States.